Treatment for Laryngeal Dystonia

Natasha J. Minaya; Phillip C. Song; Andrew Blitzer

doi:10.1016/B978-0-443-10617-0.00043-5

Treatment for Laryngeal Dystonia

Natasha J. Minaya
, Phillip C. Song
, Andrew Blitzer

Icahn School of Medicine at Mount Sinai

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Botulinum neurotoxin (BoNT) type A injections are the first-line treatment for laryngeal dystonia. This chapter provides an insightful review of office-based techniques described for accessing the intrinsic laryngeal musculature, as well as associated outcomes and potential complications.

Original language	English
Title of host publication	Office-Based Surgical Procedures in Otolaryngology
Publisher	Elsevier
Pages	253-258
Number of pages	6
ISBN (Electronic)	9780443106170
ISBN (Print)	9780443106354
DOIs	https://doi.org/10.1016/B978-0-443-10617-0.00043-5
State	Published - 1 Jan 2026

Keywords

Abductor laryngeal dystonia
abductor spasmodic dysphonia
adductor laryngeal dystonia
adductor spasmodic dysphonia
botulinum toxin treatment
laryngeal dystonia
spasmodic dysphonia

Access to Document

10.1016/B978-0-443-10617-0.00043-5

Cite this

@inbook{1a7ae9d934294d4fa449fefda6d4bf97,

title = "Treatment for Laryngeal Dystonia",

abstract = "Botulinum neurotoxin (BoNT) type A injections are the first-line treatment for laryngeal dystonia. This chapter provides an insightful review of office-based techniques described for accessing the intrinsic laryngeal musculature, as well as associated outcomes and potential complications.",

keywords = "Abductor laryngeal dystonia, abductor spasmodic dysphonia, adductor laryngeal dystonia, adductor spasmodic dysphonia, botulinum toxin treatment, laryngeal dystonia, spasmodic dysphonia",

author = "Minaya, \{Natasha J.\} and Song, \{Phillip C.\} and Andrew Blitzer",

note = "Publisher Copyright: {\textcopyright} 2027 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.",

year = "2026",

month = jan,

day = "1",

doi = "10.1016/B978-0-443-10617-0.00043-5",

language = "English",

isbn = "9780443106354",

pages = "253--258",

booktitle = "Office-Based Surgical Procedures in Otolaryngology",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Treatment for Laryngeal Dystonia

AU - Minaya, Natasha J.

AU - Song, Phillip C.

AU - Blitzer, Andrew

PY - 2026/1/1

Y1 - 2026/1/1

N2 - Botulinum neurotoxin (BoNT) type A injections are the first-line treatment for laryngeal dystonia. This chapter provides an insightful review of office-based techniques described for accessing the intrinsic laryngeal musculature, as well as associated outcomes and potential complications.

AB - Botulinum neurotoxin (BoNT) type A injections are the first-line treatment for laryngeal dystonia. This chapter provides an insightful review of office-based techniques described for accessing the intrinsic laryngeal musculature, as well as associated outcomes and potential complications.

KW - Abductor laryngeal dystonia

KW - abductor spasmodic dysphonia

KW - adductor laryngeal dystonia

KW - adductor spasmodic dysphonia

KW - botulinum toxin treatment

KW - laryngeal dystonia

KW - spasmodic dysphonia

UR - https://www.scopus.com/pages/publications/105035280344

U2 - 10.1016/B978-0-443-10617-0.00043-5

DO - 10.1016/B978-0-443-10617-0.00043-5

M3 - Chapter

AN - SCOPUS:105035280344

SN - 9780443106354

SP - 253

EP - 258

BT - Office-Based Surgical Procedures in Otolaryngology

PB - Elsevier

ER -

Treatment for Laryngeal Dystonia

Abstract

Keywords

Access to Document

Fingerprint

Cite this